1
|
Sebastià N, Olivares-González L, Montoro A, Barquinero JF, Canyada-Martinez AJ, Hervás D, Gras P, Villaescusa JI, Martí-Bonmatí L, Muresan BT, Soriano JM, Campayo JM, Andani J, Alonso O, Rodrigo R. Redox Status, Dose and Antioxidant Intake in Healthcare Workers Occupationally Exposed to Ionizing Radiation. Antioxidants (Basel) 2020; 9:antiox9090778. [PMID: 32825731 PMCID: PMC7554777 DOI: 10.3390/antiox9090778] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Revised: 08/14/2020] [Accepted: 08/18/2020] [Indexed: 12/28/2022] Open
Abstract
The purpose of this study was to evaluate the relationship between blood redox status, dose and antioxidant dietary intake of different hospital staff groups exposed to low doses of ionizing radiation (LDIR) (Interventional Radiology and Cardiology, Radiation Oncology, and Nuclear Medicine) and non-exposed. Personal dose equivalent (from last year and cumulative), plasma antioxidant markers (total antioxidant capacity, extracellular superoxide dismutase activity, and glutathione/oxidized glutathione ratio), oxidative stress markers (nitrites and nitrates, and lipid peroxidation) and dietary intake (antioxidant capacity using ORAC values) were collected and analyzed from 28 non-exposed healthcare workers and 42 healthcare workers exposed to LDIR. Hospital staff exposed to LDIR presented a redox imbalance in blood that seems to correlate with dose. Workers from the Nuclear Medicine Unit were the most affected group with the lowest value of plasma antioxidant response and the highest value of plasma thiobarbituric acid reactive substances, TBARS (indicator of lipid peroxidation) of all four groups. Cumulative personal dose equivalent positively correlated with nitrites and negatively correlated with total antioxidant capacity in blood. The diet of healthcare workers from Nuclear Medicine Unit had higher ORAC values than the diet of non-exposed. Therefore, occupational exposure to LDIR, especially for the Nuclear Medicine Unit, seems to produce an imbalanced redox status in blood that would correlate with cumulative personal dose equivalent.
Collapse
Affiliation(s)
- Natividad Sebastià
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
- Biomedical Imaging Research Group GIBI230, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain;
| | - Lorena Olivares-González
- Pathophysiology and Therapies for Visual Disorders, Eduardo Primo Yúfera, 3, Research Center Príncipe Felipe (CIPF), 46012 Valencia, Spain;
- Center for Biomedical Network Research on Rare Diseases (CIBERER), Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
| | - Alegría Montoro
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
- Biomedical Imaging Research Group GIBI230, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain;
| | - Joan-Francesc Barquinero
- Biological Anthropology Unit Animal Biology, Plant Biology and Ecology Department, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain;
| | - Antonio José Canyada-Martinez
- Biostatistics Unit, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain; (A.J.C.-M.); (D.H.)
| | - David Hervás
- Biostatistics Unit, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain; (A.J.C.-M.); (D.H.)
| | - Pilar Gras
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
| | - Juan Ignacio Villaescusa
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
- Biomedical Imaging Research Group GIBI230, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain;
| | - Luis Martí-Bonmatí
- Biomedical Imaging Research Group GIBI230, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain;
- Service of Radiology, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain
| | - Bianca Tabita Muresan
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
| | - José Miguel Soriano
- Food & Health Lab, Institute of Materials Science, Parc Científic, Catedrático Agustín Escardino, Paterna (Valencia), University of Valencia, 46980 Valencia, Spain;
- Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain
| | - Juan Manuel Campayo
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
| | - Joaquin Andani
- Service of Occupational Risk Prevention, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain;
| | - Oscar Alonso
- Service of Radiological Protection, Clinical Area of Medical Image, Avda. Fernando Abril Martorell, 106, Hospital U. P. La Fe, 46026 Valencia, Spain; (N.S.); (A.M.); (P.G.); (J.I.V.); (B.T.M.); (J.M.C.); (O.A.)
| | - Regina Rodrigo
- Pathophysiology and Therapies for Visual Disorders, Eduardo Primo Yúfera, 3, Research Center Príncipe Felipe (CIPF), 46012 Valencia, Spain;
- Center for Biomedical Network Research on Rare Diseases (CIBERER), Monforte de Lemos, 3-5. Pabellón 11, 28029 Madrid, Spain
- Joint Research Unit on Endocrinology, Nutrition and Clinical Dietetics, University of Valencia, Avda. Fernando Abril Martorell, 106, Health Research Institute Hospital La Fe (IISLaFe), 46026 Valencia, Spain
- Joint Research Unit of Rare Diseases, CIPF-Health Research Institute La Fe, Eduardo Primo Yúfera, 3, 46012 Valencia, Spain
- Correspondence: ; Tel.: +34-96-328-9680
| |
Collapse
|
4
|
Campbell BA, Callahan J, Bressel M, Simoens N, Everitt S, Hofman MS, Hicks RJ, Burbury K, MacManus M. Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning. Int J Radiat Oncol Biol Phys 2015; 92:1035-1043. [PMID: 26194679 DOI: 10.1016/j.ijrobp.2015.04.027] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2014] [Revised: 04/10/2015] [Accepted: 04/14/2015] [Indexed: 02/03/2023]
Abstract
PURPOSE Proliferating bone marrow is exquisitely sensitive to ionizing radiation. Knowledge of its distribution could improve radiation therapy planning to minimize unnecessary marrow exposure and avoid consequential prolonged myelosuppression. [18F]-Fluoro-3-deoxy-3-L-fluorothymidine (FLT)-positron emission tomography (PET) is a novel imaging modality that provides detailed quantitative images of proliferating tissues, including bone marrow. We used FLT-PET imaging in cancer patients to produce an atlas of marrow distribution with potential clinical utility. METHODS AND MATERIALS The FLT-PET and fused CT scans of eligible patients with non-small cell lung cancer (no distant metastases, no prior cytotoxic exposure, no hematologic disorders) were reviewed. The proportions of skeletal FLT activity in 10 predefined bony regions were determined and compared according to age, sex, and recent smoking status. RESULTS Fifty-one patients were studied: 67% male; median age 68 (range, 31-87) years; 8% never smokers; 70% no smoking in the preceding 3 months. Significant differences in marrow distribution occurred between sex and age groups. No effect was detected from smoking in the preceding 3 months. Using the mean percentages of FLT uptake per body region, we created an atlas of the distribution of functional bone marrow in 4 subgroups defined by sex and age. CONCLUSIONS This atlas has potential utility for estimating the distribution of active marrow in adult cancer patients to guide radiation therapy planning. However, because of interindividual variation it should be used with caution when radiation therapy risks ablating large proportions of active marrow; in such cases, individual FLT-PET scans may be required.
Collapse
Affiliation(s)
- Belinda A Campbell
- Department of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Australia.
| | - Jason Callahan
- Centre for Molecular Imaging, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Mathias Bressel
- Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Nathalie Simoens
- Centre for Molecular Imaging, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Sarah Everitt
- Radiotherapy Services, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Michael S Hofman
- Centre for Molecular Imaging, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Rodney J Hicks
- Centre for Molecular Imaging, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Kate Burbury
- Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Australia
| | - Michael MacManus
- Department of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne, Australia
| |
Collapse
|
6
|
Giardi MT, Touloupakis E, Bertolotto D, Mascetti G. Preventive or potential therapeutic value of nutraceuticals against ionizing radiation-induced oxidative stress in exposed subjects and frequent fliers. Int J Mol Sci 2013; 14:17168-92. [PMID: 23965979 PMCID: PMC3759958 DOI: 10.3390/ijms140817168] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Revised: 08/01/2013] [Accepted: 08/12/2013] [Indexed: 12/19/2022] Open
Abstract
Humans are constantly exposed to ionizing radiation deriving from outer space sources or activities related to medical care. Absorption of ionizing radiation doses over a prolonged period of time can result in oxidative damage and cellular dysfunction inducing several diseases, especially in ageing subjects. In this report, we analyze the effects of ionizing radiation, particularly at low doses, in relation to a variety of human pathologies, including cancer, and cardiovascular and retinal diseases. We discuss scientific data in support of protection strategies by safe antioxidant formulations that can provide preventive or potential therapeutic value in response to long-term diseases that may develop following exposure.
Collapse
Affiliation(s)
| | - Eleftherios Touloupakis
- Biosensor, Via Olmetti 44 Formello, Rome 00060, Italy; E-Mail:
- Department of Chemistry, University of Crete, P.O. Box 2208, Voutes-Heraklion 71003, Greece
| | - Delfina Bertolotto
- Agenzia Spaziale Italiana (ASI), Viale Liegi 26, Rome 00198, Italy; E-Mails: (D.B.); (G.M.)
| | - Gabriele Mascetti
- Agenzia Spaziale Italiana (ASI), Viale Liegi 26, Rome 00198, Italy; E-Mails: (D.B.); (G.M.)
| |
Collapse
|